RUNX inhibitor suppresses graft-versus-host disease through targeting RUNX-NFATC2 axis.
Kubota H, Masuda T, Noura M, Furuichi K, Matsuo H, Hirata M, Kataoka TR, Hiramatsu H, Yasumi T, Nakahata T, Imai Y, Takita J, Adachi S, Sugiyama H, Kamikubo Y.
Kubota H, et al. Among authors: nakahata t.
EJHaem. 2021 May 19;2(3):449-458. doi: 10.1002/jha2.230. eCollection 2021 Aug.
EJHaem. 2021.
PMID: 35844683
Free PMC article.